News | News By Subject | News by Disease News By Date | Search News

Coronary artery disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Isis Pharmaceuticals, Inc. (ISIS)'s apoC-III Shown to Significantly Reduce Triglycerides     4/1/2013
FDA Advisory Committee Recommends Approval of AstraZeneca PLC (AZN)'s Brilinta (Ticagrelor) for Acute Coronary Syndromes; AstraZeneca Lifts Forecast Due to Ruling     7/29/2010
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate     11/13/2008
CV Therapeutics, Inc. (CVTX) (JOBS) Says FDA Continues to Review Ranexa(R) Applications Beyond PDUFA Action Date     7/28/2008
CHMP Recommends Expanded Use of The Medicines Company (MDCO)'s Angiox(R) (Bivalirudin) in Europe     11/19/2007
Nuvelo, Inc. (NUVO) to Cut 30% Jobs, Suspends Trials     8/2/2007
Alchemia Release: Arixtra(R) Receives Priority Review By The FDA In Acute Coronary Syndromes (ACS)     10/4/2006
FDA Grants Priority Review For GlaxoSmithKline (GSK)'s ARIXTRA(R) (fondaparinux sodium) In The Treatment Of Acute Coronary Syndromes     10/3/2006
Medicure Inc. (MCU) Acquires U.S. Rights To Aggrastat'R' From MGI PHARMA, INC. (MOGN); Medicure To Pay $19 Million     8/9/2006
Merck & Co., Inc. (MRK) Announces Preliminary Analyses Of Off-Drug Extension Of APPROVe Study; Study Suggests No Added Risk After Stopping Vioxx     5/12/2006
GenVec Inc. (GNVC) Halts Enrollment Of Phase II Trial For Heart Drug     5/10/2006
Eli Lilly and Company (LLY) Statement On STAR; Drug Cuts Breast Cancer Risk, Fewer Side-Effects     4/18/2006

News from Around the Web
Optimism Linked to Improved Survival With Coronary Artery Disease, University of Pennsylvania Study     3/1/2011
New Questions About Pre-Op Beta-Blockers, Heart Hospital Baylor Study     2/1/2011
Noise on the Job Linked to Coronary Heart Disease, University of British Columbia Study     10/6/2010
Newer Antiplatelets Best Clopidogrel, Pitie-Salpetriere Hospital Study     8/26/2010
Cocoa Flavanols Could More Than Double Cells Associated With Repair And Maintenance Of Blood Vessels, According To Mars Inc. Research     7/6/2010
New Method to Grow Arteries Could Lead to 'Biological Bypass' for Heart Disease, Yale University School Of Medicine Study     3/9/2010
American Heart Association Report: Drinking Sugar-sweetened Beverages Daily Linked to Diabetes, Cardiovascular Disease, Increased Healthcare Costs     3/5/2010
Adding Ezetimibe To Atorvastatin Improves Lipid Control, University Of Montreal Study Finds     10/27/2009
Drug May Reduce Coronary Artery Plaque, Sakakibara Heart Institute Of Okayama Study     10/13/2008
Government Probes Chelation-Heart Disease Study; Enrollment Stopped In National Institutes of Health (NIH)-Funded Trial Studying Chelation Therapy For Treatment Of CAD     9/26/2008
POINT Biomedical Corporation's Vanishing Act -- What Happened?     8/27/2008
Eye Abnormality Elevates Heart Disease Death Risk, University of Sydney, University of Melbourne, and National University of Singapore Study     8/13/2008
Volunteers Needed For Chocolate Study, University of East Anglia     4/28/2008
Proteins That Stop A Major Signaling Pathway Can Also Generate New Proteins, Duke University Medical Center Study     4/25/2008
One Drink Of Red Wine Or Alcohol Is Relaxing To Circulation, But Two Drinks Are Stressful     2/14/2008

Press Releases
Bayer (BAY) Release: COMPASS Study Presented At ESC Congress 2017 – Largest Rivaroxaban Study To Date, Enrolled 27,395 Patients To Investigate CAD And PAD     8/28/2017
Acarix Receives First German Commercial Order For CADScor System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin     7/5/2017
New Study With Abiomed (ABMD)’s Impella 2.5 Heart Pump Demonstrates Potential Survival With Pre-PCI Insertion In Heart Attacks With The Left Main Coronary Artery     6/30/2017
Amgen (AMGN)'s Repatha Unclogs Blocked Arteries in Key Study     11/16/2016
Stentys Enrolls First Patient In Left Main Clinical Trial     7/19/2016
Health Canada Clears Abbott (ABT)'s Absorb Bioresorbable Stent     7/15/2016
One-Year PLATFORM Trial Results Reinforce Benefits Of The Heartflow FFRCT Analysis For Assessing Coronary Artery Disease     4/4/2016
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In Updated American College of Cardiology And AHA Guideline In Acute Coronary Syndrome     3/31/2016
Global Genomics Group And GNS Healthcare Report Preliminary Results Of Largest-Ever Study Linking Biomarkers With Coronary Artery Disease     1/8/2016
The Medicines Company (MDCO) Announces Investigational Lipid Modulating Agent, MDCO-216, Phase 1 Data Published In European Heart Journal- Cardiovascular Pharmacotherapy     12/15/2015
Resverlogix (RVX.TO) Commences Dosing In Phase 3 Clinical Trial Betonmace     11/11/2015
Resverlogix (RVX.TO) Commences Phase 3 Clinical Trial BETonMACE With Apabetalone     10/26/2015
International Clinical Steering Committee Announced For Resverlogix (RVX.TO)'s Phase 3 Betonmace Clinical Trial With RVX-208 "Apabetalone"     8/4/2015
Cardiome Pharma Corp. (COM.TO) Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada     7/22/2015
Micell Technologies Announces First Patient Enrolled In Registration Trial Of Mistent SES In China     7/22/2015